[1]
Bashir, A. et al. 2026. Response Assessment to Neoadjuvant Treatment with Dual HER2 Blocker in HER2 positive Early and Locally Advanced Breast Cancer. Pakistan Armed Forces Medical Journal. 76, SUPPL-5 (May 2026), S729-S732. DOI:https://doi.org/10.51253/pafmj.v76iSUPPL-5.10388.